Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases

被引：13

作者：

Peters, Laurenna ^{[2
]}

McCarthy, Anne E. ^{[1
]}

Faught, Carolyn ^{[1
]}

机构：

[1] Univ Ottawa, Trop Med & Int Hlth Clin, Div Infect Dis, Ottawa, ON K1H 8L6, Canada

[2] Univ British Columbia, Div Infect Dis, Postgrad Training Program, Vancouver, BC V5Z 1M9, Canada

来源：

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2009年 / 13卷 / 06期

关键词：

Strongyloides; Ivermectin secondary prophylaxis; Hyperinfection; Disseminated strongyloidiasis; HTLV-1-associated malignancy; HYPERINFECTION SYNDROME; IVERMECTIN; EFFICACY;

D O I：

10.1016/j.ijid.2009.02.009

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Secondary ivermectin prophylaxis for strongyloidiasis in two patients with human T-cell lymphotropic virus type 1 (HTLV-1)-associated malignancies and fully treated complicated strongyloidiasis is described. Treatment was well tolerated and neither patient developed further manifestations of hyperinfection. As treatment failure for complicated strongyloidiasis has been documented in severely immunosuppressed patients, secondary prophylaxis may be indicated. (C) 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

引用

页码：E501 / E503

页数：3

共 18 条

[1] Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru [J].

Gotuzzo, E ;

Terashima, A ;

Alvarez, H ;

Tello, R ;

Infante, R ;

Watts, DM ;

Freedman, DO .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 60 (01) :146-149

[2] Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin [J].

Haubner, HP ;

Galle, J ;

Chiodini, PL ;

Rupp, J ;

Birke, R ;

Vollmer, E ;

Zabel, P ;

Lange, C .

INFECTION, 2005, 33 (5-6) :383-386

[3] Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan [J].

Hayashi, J ;

Kishihara, Y ;

Yoshimura, E ;

Furusyo, N ;

Yamaji, K ;

Kawakami, Y ;

Murakami, H ;

Kashiwagi, S .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1997, 56 (01) :71-75

[4]

Higashiyama Y, 1997, Kansenshogaku Zasshi, V71, P680

[5]

IGRASIEGMAN Y, 1981, REV INFECT DIS, V3, P397

[6] Strongyloides stercoralis in the immunocompromised population [J].

Keiser, PB ;

Nutman, TB .

CLINICAL MICROBIOLOGY REVIEWS, 2004, 17 (01) :208-+

[7] APPLICATION OF ENZYME-IMMUNOASSAY FOR POSTCHEMOTHERAPY EVALUATION OF HUMAN STRONGYLOIDIASIS [J].

KOBAYASHI, J ;

SATO, Y ;

TOMA, H ;

TAKARA, M ;

SHIROMA, Y .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 18 (01) :19-23

[8] Disseminated strongyloidiasis: a retrospective study of clinical course and outcome [J].

Lam, CS ;

Tong, MKH ;

Chan, KM ;

Siu, YP .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (01) :14-18

[9] Complicated and fatal Strongyloides infection in Canadians:: risk factors, diagnosis and management [J].

Lim, S ;

Katz, K ;

Krajden, S ;

Fuksa, M ;

Keystone, AS ;

Kain, KC .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (05) :479-484

[10] Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area [J].

Loutfy, MR ;

Wilson, M ;

Keystone, JS ;

Kain, KC .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2002, 66 (06) :749-752

← 1 2 →